| Avaliação farmacológica da atividade antimuscarínica de novas substâncias multi-alvos para tratamento da doença de Alzheimer (Menção Honrosa) |
|
2023 |
| Propriedades elétricas de células da microglia e papel de seus receptores ionotrópicos na neuroinflamação (Menção Honrosa) |
|
2023 |
| Análise da correlação entre tempo de isquemia, tamanho da lesão cerebral e déficits neurológicos em modelo de AVE isquêmico em camundongos (Menção Honrosa) |
|
2023 |
| Anticholinesterase-antimuscarinics: Study of dual agents aiming at application for Alzheimer?s disease (Menção Honrosa) |
|
2019 |
| Caracterização dos receptores nicotínicos de acetilcolina em macrófagos (Menção Honrosa) |
|
2019 |
| Blockade of cannabinoid type 2 receptor inhibits a working memory impairment relevant for schizophrenia |
|
2019 |
| Neuroprotective effect of arylnitrones in vitro models of stroke. (Premiado com Menção Honrosa) |
|
2018 |
| Search of novel phenylpiperidine cholinesterase inhibitors for Alzheimer's disease with less cholinergic side effects |
|
2018 |
| Neuroprotective effect of arylnitrones in vitro models of stroke |
|
2018 |
| Métodos Longa e Koizumi diferem em tamanho de infarto e sucesso cirúrgico em modelo animal de AVC |
|
2018 |
| Receptores nicotínicos alfa 7 de acetilcolina em macrófagos: associação da atividade do canal com aumento de cálcio intracelular |
|
2018 |
| Estudo piloto para a avaliação de sequelas sensório-motoras em camundongos submetidos ao acidente vascular encefálico isquêmico |
|
2018 |
| Comparação das propriedades de receptores nicotínicos em macrófagos e neurônios |
|
2017 |
| Acetylcholinesterase inhibition and anti-amnesic effects of new dual compounds candidates for Alzheimer?s disease treatment (Menção Honrosa) |
|
2016 |
| New cholinesterase inhibitors derived from cardanol for Alzheimer?s disease (Menção Honrosa) |
|
2016 |
| Protocol development to study the modulation of long-term excitatory synaptic plasticity in hippocampal slices |
|
2015 |
| New cholinesterase inhibitors derived from cardanol for Alzheimer?s disease |
|
2015 |
| LFQM 75: New lead compound for Alzheimer?s disease treatment (Menção Honrosa) |
|
2015 |
| Desenvolvimento de protocolos para estudo da modulação da plasticidade sináptica excitatória de longa duração em fatias de hipocampo |
|
2014 |
| Estudo de novos anticolinesterásicos para o tratamento da doença de Alzheimer |
|
2014 |
| Ethnomedical knowledge among the ?Quilombolas? from Oriximiná, Brazil, with a special focus on plants used as nerve tonics |
|
2012 |
| Efeitos de LASSBio-767 sobre receptores muscarínicos M2 e M3 e corrente tônica GABAérgica hipocampal |
|
2011 |
| Synthesis and pharmacological evaluation of novel 3-acetyl and 3-carbamoyl-piperidine analogues of donepezil designed as symbiotic antiinflammatory and anticholinesterase drug candidates |
|
2011 |
| Novos análogos do donepezil com atividade dupla, inibidores de acetilcolinesterase e anti-inflamatórios, planejados como candidatos a novos fármacos para o tratamento da doença de Alzheimer |
|
2011 |
| Structure-activity of LB-294 derivatives on cannabinoid and vanilloid receptors |
|
2011 |
| Neuroactive properties of the multifunctional prototype LASSBio-881: focus on the cannabinoid system |
|
2011 |
| Heterologous expression of mouse cannabinoid receptor 1 (CB1) in Xenopus laevis oocytes and the action of LASSBio-881 on these receptors |
|
2011 |
| Excessive gabaergic stimulation is associated with neuronal death and increased nicotinic receptor function |
|
2011 |
| Effects of LASSBio-767 on M2 and M3 muscarinic receptors and hippocampal gabaergic tonic current |
|
2011 |
| d-Serine regulates the formation of excitatory synapses through NMDA receptor binding in the cerebral cortex |
|
2011 |
| Cellular assessment after unilateral rat spinal cord injury: correlation with functional recovery |
|
2011 |
| P2X pore formation is inhibited by colchicine: a possible mechanism for its anti-inflammatory actions |
|
2011 |
| Transforming growth factor beta 1 induces excitatory synapses of cerebral cortex neurons |
|
2011 |
| Comparative study of two Aspidosperma species used by ?quilombola? communities of Oriximiná (Brazil): chromatographic profiles and acetylcholinesterase inhibitory activity |
|
2010 |
| LASSBio-881: an N-acylhydrazone TRPV1 antagonist orally effective against capsaicin- and partial sciatic ligation-induced hypernociception |
|
2010 |
| Characterization of the antimuscarinic effect of LASSBio-767 in HT-29 cells |
|
2010 |
| LASSBio-294 has partial agonist and antagonistic actions on TRPV1 |
|
2010 |
| Effect of LASSBio-767 on apoptosis and inhibitory synaptic transmission |
|
2010 |
| Avaliação da atividade anticolinesterásica de alcalóides indólicos monoterpênicos isolados de Apocynaceae |
|
2010 |
| Evaluation of probenecid?s neuroprotective effect on excitotoxic and ischemic neural lesion |
|
2009 |
| LASSBio-767: a semi-synthetic Alzheimer?s disease drug prototype combining anticholinesterase and muscarinic M3 inhibitory activities |
|
2009 |
| Evaluation of pre- and post-treatment with LASSBio 881 in the reduction of infarct volume in mice submitted to focal cerebral ischemia |
|
2009 |
| Pharmacological evaluation in vitro of new substances derived from cardanol with potential application in Alzheimer?s disease |
|
2009 |
| Characterization of a novel cannabinoid-1 (CB1) inverse agonist: interaction with receptors expressed in Xenopus oocytes, synaptic modulation and hypophagic effect |
|
2009 |
| Effects of vigabatrin on the activity of nicotinic receptors from the rat hippocampus |
|
2009 |
| Interaction of (-)-3-O-acetyl-spectaline hydrochloride (LASSBio-767) with the acetylcholinesterase peripheral anionic site |
|
2009 |
| LASSBio-579, an antipsychotic lead compound, increases synaptic glutamate release in rat cultured hippocampal neurons |
|
2009 |
| Characterization of a novel TRPV1 antagonist with analgesic activity in a model of neuropathic pain |
|
2009 |
| Síntese e avaliação de novos candidatos a inibidores de acetilcolinesterase planejados a partir do cardanol |
|
2009 |
| Interação do cloridrato de (-)-3-O-acetilespectalina (LASSBio-767) com o sítio aniônico periférico da acetilcolinesterase |
|
2009 |
| Avaliação farmacológica in vitro de novas substâncias derivadas de cardanol com potencial aplicação na doença de Alzheimer |
|
2009 |
| Ensaios fluorimétricos de moduladores do influxo de cálcio mediado por receptores nicotínicos neuronais |
|
2009 |
| Síntese e otimização de novos candidatos a fármacos simbióticos, planejados como anti-inflamatórios e anti-colinesterásicos |
|
2009 |
| Síntese e avaliação farmacológica de novos candidatos a inibidores de acetilcolinesterase planejados por hibridação molecular |
|
2008 |
| Molecular modeling studies of semi?synthetic piperidine anti?Alzheimer prototypes |
|
2008 |
| Donepezil-acylhydrazone derivatives: A new series of antiinflammatory and acetylcholinesterase inhibitors |
|
2008 |
| Characterization of new natural alkaloids as potent inhibitors of nicotinic receptors |
|
2008 |
| Vigabatrin modulates alpha7 nicotinic receptors in cultured hippocampal neurons |
|
2008 |
| Behavioral and electrophysiological evaluation of peripheral nerve regeneration after lesion |
|
2007 |
| Avaliação do efeito neuroprotetor da probenecida na lesão neural excitotóxica e isquêmica |
|
2007 |
| A novel amino acid with activity in brain NMDA receptors |
|
2007 |
| Síntese e avaliação farmacológica de novos agentes inibidores de acetilcolinesterase planejados por hibridação molecular |
|
2007 |
| Triagem de extratos vegetais na inibição in vitro da acetilcolinesterase: Um estudo crítico |
|
2007 |
| Atividade inibitória da acetilcolinesterase por extratos de diferentes polaridades de folhas de Rollinia sylvatica |
|
2007 |
| Caracterização funcional dos receptores nicotínicos expressos em células da linhagem PC12: Interação com alcalóides de Erythrina mulungu |
|
2007 |
| Registros eletrofisiológicos em ovócitos de Xenopus para identificação de novos moduladores seletivos de receptores de NMDA |
|
2007 |
| Morphological, behavioral and electrophysiological evaluation of peripheral nerve regeneration after lesion and treatment with bone marrow derived cells |
|
2006 |
| Estudo do perfil antiinflamatório e analgésico do composto LASSBio 930 |
|
2006 |
| Avaliação do efeito neuroprotetor da probenecida na lesão neural excitotóxica e isquêmica |
|
2006 |
| Modelos moleculares de atividade de receptores canabinóides e vanilóides: novas vias de transdução de sinais |
|
2006 |
| N-Heteroarylcarbonylalanines as selective ligands for glutamate receptors of subtype NMDA: stereoselective synthesis and preliminary evaluation |
|
2006 |
| Efeito neuroprotetor da probenecida sobre a morte neuronal induzida pelo glutamato: envolvimento de AMPc e GMPc |
|
2005 |
| Caracterização de novos alcalóides semi-sintéticos como inibidores de colinesterases |
|
2005 |
| Papel das cinases dependentes dos nucleotídios cíclicos na ativação de células Y-1 derivadas de córtex suprarrenal de camundongo |
|
2005 |
| Papel dos nucleotídeos cíclicos e fosfodiesterases na proliferação da linhagem Y-1 de células tumorais da suprarrenal |
|
2005 |
| Caracterização funcional dos receptores nicotínicos expressos em células da linhagem PC12 |
|
2005 |
| Effect of MK-801 on the motility of Schistosoma mansoni: evidence for interaction with nicotinic receptors |
|
2004 |
| Novos candidatos a fármacos anticolinesterásicos planejados a partir de alcalóides piperidínicos de Senna spectabilis (Leguminosae) |
|
2004 |
| Estudo do perfil antiinflamatório e analgésico de novos derivados N-acilidrazônicos análogos do composto LASSBio 294 |
|
2004 |
| New semi-synthetic piperidine alkaloids active as brain cholinesterase inhibitors with low toxicity |
|
2004 |
| Role of synaptic activity in modulating alpha-7 nicotinic receptor currents in hippocampal neurons |
|
2003 |
| Cyclic nucleotide phosphodiesterases (PDE) as targets of atrial natriuretic peptide (ANP) signaling in Y-1 adrenal cortical cells |
|
2003 |
| Novel amino acids with activity in brain NMDA receptors |
|
2003 |
| Effect of PCALC36, a new synthetic coumestan, on GABAA receptors |
|
2003 |
| Papel da fosfodiesterase (PDE) tipo 2 na morte neuronal induzida pelo glutamato |
|
2003 |
| Modulação dos efeitos dos nucleotídios cíclicos pelas fosfodiesterases em células Y-1 de tumor de córtex supra-renal |
|
2003 |
| Caracterização de novos alcalóides semi-sintéticos como inibidores de colinesterases cerebrais |
|
2003 |
| Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the brain |
|
2002 |
| Alpha7 nicotinic receptor expression in CA1 and CA3 pyramidal neurons is regulated by septal innervation of the hippocampus |
|
2002 |
| Síntese e avaliação farmacológica de novas 1,4-naftoquinonas estruturalmente relacionadas ao lapachol |
|
2002 |
| Toxicological studies of LASSBio 294, a new thienylacylhydrazone positive inotropic agent |
|
2002 |
| Modulation of alpha-7 nicotinic receptor currents by synaptic activity in hippocampal neurons |
|
2002 |
| Neuroprotective properties of novel conformationally restricted amino acids |
|
2002 |
| Cyclic-GMP-stimulated phosphodiesterase (PDE2) modulates the effects of cyclic AMP in Y-1 adrenal cortical cells |
|
2002 |
| Role of phosphodiesterases (PDE) in neuronal death induced by glutamate |
|
2002 |
| Modulação dos efeitos do AMP cíclico em células Y-1 de córtex suprarrenal pela fosfodiesterase estimulada por GMPc (PDE2) |
|
2002 |
| Propriedades neuroprotetoras de novos aminoácidos conformacionalmente restritos |
|
2002 |
| Protection or rat cortical neurons against glutamate and nitric oxide toxicity by LASSBio-294 |
|
2001 |
| Role of the cyclic nucleotides cAMP and cGMP in neuronal death induced by glutamate |
|
2001 |
| Electrophysiological analysis of a new ligand of the benzodiazepine site on GABAA receptors |
|
2001 |
| Role of cyclic nucleotides in the neuroprotective effect of LASSBio-294 |
|
2001 |
| Septal innervation of the hippocampus regulates expression of alpha7 nicotinic receptors in CA1 and CA3 pyramidal neurons. |
|
2001 |
| The novel thienylhydrazone LASSBio-294 increases inotropism and decreases fatigue of skeletal muscle |
|
2001 |
| Role of the cyclic nucleotides cAMP and cGMP in neuronal death induced by glutamate |
|
2001 |
| Protection of rat cortical neurons against glutamate and nitric oxide toxicity by LASSBio-294 |
|
2001 |
| Electrophysiological analysis of new ligands of the benzodiazepine site on GABAA receptors |
|
2001 |
| Neuronal excitation modulates expression of alpha7 nicotinic acetylcholine receptor currents in rat hippocampal neurons |
|
2001 |
| A expressão de receptores nicotínicos em neurônios piramidais do hipocampo é regulada pela inervação do septo |
|
2001 |
| A novel thienylhydrazone increases inotropism and decreases fatigue of skeletal muscle |
|
2001 |
| Papel do nucleotídeos cýclicos AMPc e GMPc na morte neuronal induzida por glutamato |
|
2001 |
| Protection against glutamate-induced neurotoxicity by LASSBio 294: possible involvement of cyclic nucleotides |
|
2000 |
| Dissociation kinetics distinguishes acetylcholine and choline as alpha7 nicotinic receptor agonists in rat hippocampal neurons |
|
2000 |
| Choline activates alpha-bungarotoxin-sensitive nicotinic receptors in CA1 pyramidal neurons of organotypic hippocampal cultures: regulation of receptor expression by septal innervation |
|
2000 |
| Modeling the affinity shift between acetylcholine and choline at the alpha7 nicotinic receptor |
|
2000 |
| Synthesis and assay of tacrine-like analogs with cholinesterase inhibition properties |
|
2000 |
| Choline as another agonist that may bind after (or instead of) acetylcholine at central alpha7 nicotinic receptors |
|
2000 |
| Protection against glutamate-induced neurotoxicity by LASSBio 294: cyclic nucleotides as targets |
|
2000 |
| Novel ligands of the benzodiazepine site of GABAA receptor channels |
|
2000 |
| Choline activates alpha-bungarotoxin-sensitive nicotinic receptors in CA1 pyramidal neurons of organotypic hippocampal cultures: regulation of receptor expression by septal innervation |
|
2000 |
| Triagem farmacológica de novos fármacos sintéticos com alvo em receptores neuronais de glutamato |
|
2000 |
| Biphasic effects of lead (Pb2+) on alpha7 nicotinic acetylcholine receptors of cultured hippocampal neurons |
|
1999 |
| Ensaio funcional de novos ligantes do receptor GABAA atuantes em sítios do GABA ou dos benzodiazepínicos |
|
1999 |
| Caracterização Funcional de Uma Cultura Organotípica de Hipocampo de Rato |
|
1998 |
| Efeitos de Baixas Concentrações de Piridostigmina Em Potenciais Excitatórios No Hipocampo do Rato |
|
1998 |
| Tratamento Despolarizante Promove Um Aumento das Respostas Nicotínicas do Tipo Alfa7 Em Neurônios Hipocampais de Rato |
|
1998 |
| Efeitos de Concentrações Nanomolares de Piridostigmina Em Potenciais Excitatórios No Hipocampo de Rato |
|
1998 |
| Pyridostigmine At Nanomolar Concentrations Potentiates Excitatory Neurotransmission At Schaffer-Ca1 Hippocampal Synapses |
|
1998 |
| Caracterização Morfológica e Funcional de Uma Cultura Organotípica de Hipocampo de Rato |
|
1997 |
| High-Potassium Treatment Increases Alpha7 Nicotinic Receptor-Gated Currents In Cultured Rat Hippocampal Neurons |
|
1997 |
| Direct Inhibition Of The Nmda Receptor: An Atypical Efect Of Dopamine |
|
1996 |
| Methamidophos, But Not Aldicarb, Is A Pure Cholinesterase Inhibitor |
|
1996 |
| Fast Inhibition Of N-Methyl-D-Aspartate (Nmda) Receptor Functon: An Atypical Effect Of Dopamine |
|
1995 |
| Calcium Permeability Of Hippocampal Alfa7 Nicotinic Acetylcholine Receptor Channels |
|
1994 |
| Ca2+ Permeability Of Alfa-Bungarotoxin-Sensitive Hippocampal Nicotinicreceptors |
|
1994 |
| Correntes Unitarias e Seletividade Ionica do Receptor Nicotinico Neuronal Sensivel A Alfa-Bungarotoxina |
|
1994 |
| Fast Kinetics And Calcium Permeability Of Alfa-Bungarotoxin-Sensitive Hippocampal Nicotinic Receptor Channels |
|
1993 |
| Functional Characterization Of A Second Agonist Binding Site On Nicotinic Acetylcholine Receptors (Nachrs) |
|
1992 |
| Point Process Analysis Of Frog Endplate Single Channel Currents |
|
1991 |
| Analise Ponto-Evento da Ativacao do Receptor Nicotinico Periferico |
|
1991 |